company background image
GXI logo

Gerresheimer XTRA:GXI Voorraadrapport

Laatste prijs

€78.60

Marktkapitalisatie

€2.7b

7D

-4.3%

1Y

-12.4%

Bijgewerkt

03 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

GXI Overzicht aandelen

Gerresheimer AG produceert en verkoopt samen met haar dochterondernemingen medicijnverpakkingen, toedieningshulpmiddelen en oplossingen in Duitsland en internationaal.

Gerresheimer AG Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Gerresheimer
Historische aandelenkoersen
Huidige aandelenkoers€78.60
52 Week Hoogtepunt€111.20
52 Week Laag€76.10
Bèta0.94
11 maand verandering-0.63%
3 maanden verandering-14.24%
1 Jaar Verandering-12.42%
33 jaar verandering-1.69%
5 jaar verandering7.23%
Verandering sinds IPO104.95%

Recent nieuws en updates

Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Oct 03
Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Sep 29
Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

Aug 31
Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

Recent updates

Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Oct 03
Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Sep 29
Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

Aug 31
Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

Shareholders Will Most Likely Find Gerresheimer AG's (ETR:GXI) CEO Compensation Acceptable

May 30
Shareholders Will Most Likely Find Gerresheimer AG's (ETR:GXI) CEO Compensation Acceptable

Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

May 22
Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 40% Undervalued

May 03
An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 40% Undervalued

Analysts Are Updating Their Gerresheimer AG (ETR:GXI) Estimates After Its First-Quarter Results

Apr 14
Analysts Are Updating Their Gerresheimer AG (ETR:GXI) Estimates After Its First-Quarter Results

Gerresheimer's (ETR:GXI) Dividend Will Be €1.25

Apr 12
Gerresheimer's (ETR:GXI) Dividend Will Be €1.25

Gerresheimer (ETR:GXI) Has A Somewhat Strained Balance Sheet

Apr 10
Gerresheimer (ETR:GXI) Has A Somewhat Strained Balance Sheet

Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25

Feb 25
Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25

Investors Still Waiting For A Pull Back In Gerresheimer AG (ETR:GXI)

Feb 10
Investors Still Waiting For A Pull Back In Gerresheimer AG (ETR:GXI)

At €92.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?

Jan 23
At €92.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?

Are Investors Undervaluing Gerresheimer AG (ETR:GXI) By 28%?

Jan 03
Are Investors Undervaluing Gerresheimer AG (ETR:GXI) By 28%?

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Dec 15
Is Gerresheimer (ETR:GXI) Using Too Much Debt?

When Should You Buy Gerresheimer AG (ETR:GXI)?

Oct 19
When Should You Buy Gerresheimer AG (ETR:GXI)?

An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 42% Undervalued

Oct 01
An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 42% Undervalued

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Aug 26
Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Should You Investigate Gerresheimer AG (ETR:GXI) At €105?

Jul 06
Should You Investigate Gerresheimer AG (ETR:GXI) At €105?

Gerresheimer AG's (ETR:GXI) Intrinsic Value Is Potentially 94% Above Its Share Price

Jun 18
Gerresheimer AG's (ETR:GXI) Intrinsic Value Is Potentially 94% Above Its Share Price

Gerresheimer (ETR:GXI) Is Paying Out A Dividend Of €1.25

Apr 05
Gerresheimer (ETR:GXI) Is Paying Out A Dividend Of €1.25

Is Gerresheimer (ETR:GXI) A Risky Investment?

Mar 17
Is Gerresheimer (ETR:GXI) A Risky Investment?

Gerresheimer's (ETR:GXI) Dividend Will Be €1.25

Feb 27
Gerresheimer's (ETR:GXI) Dividend Will Be €1.25

What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?

Feb 15
What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Nov 18
Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Is Now An Opportune Moment To Examine Gerresheimer AG (ETR:GXI)?

Sep 06
Is Now An Opportune Moment To Examine Gerresheimer AG (ETR:GXI)?

Is Gerresheimer (ETR:GXI) A Risky Investment?

Aug 18
Is Gerresheimer (ETR:GXI) A Risky Investment?

Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

May 31
Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Gerresheimer (ETR:GXI) Will Pay A Dividend Of €1.25

May 16
Gerresheimer (ETR:GXI) Will Pay A Dividend Of €1.25

Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25

May 02
Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25

Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25

Apr 18
Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25

Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25

Apr 04
Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25

Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Mar 21
Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Mar 06
Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Feb 20
Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

At €72.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?

Feb 17
At €72.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?

Is Gerresheimer (ETR:GXI) A Risky Investment?

Jan 06
Is Gerresheimer (ETR:GXI) A Risky Investment?

What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?

Nov 04
What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?

Does Gerresheimer (ETR:GXI) Have A Healthy Balance Sheet?

Sep 23
Does Gerresheimer (ETR:GXI) Have A Healthy Balance Sheet?

Is Gerresheimer AG (ETR:GXI) Trading At A 24% Discount?

Sep 05
Is Gerresheimer AG (ETR:GXI) Trading At A 24% Discount?

Should You Think About Buying Gerresheimer AG (ETR:GXI) Now?

Jul 11
Should You Think About Buying Gerresheimer AG (ETR:GXI) Now?

Is Gerresheimer (ETR:GXI) A Risky Investment?

Jun 24
Is Gerresheimer (ETR:GXI) A Risky Investment?

Rendement voor aandeelhouders

GXIDE Life SciencesDE Markt
7D-4.3%-0.6%-1.8%
1Y-12.4%15.3%13.2%

Rendement versus industrie: GXI presteerde slechter dan de German Life Sciences -sector, die het afgelopen jaar een rendement van 15.3 % opleverde.

Rendement versus markt: GXI presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 13.2 % opleverde.

Prijsvolatiliteit

Is GXI's price volatile compared to industry and market?
GXI volatility
GXI Average Weekly Movement6.6%
Life Sciences Industry Average Movement6.6%
Market Average Movement5.0%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

Stabiele aandelenkoers: GXI heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van GXI is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
186412,012Dietmar Siemssenwww.gerresheimer.com

Gerresheimer AG produceert en verkoopt samen met haar dochterondernemingen medicijnverpakkingen, toedieningshulpmiddelen en oplossingen in Duitsland en internationaal. Het bedrijf is actief via drie divisies: Plastics & Devices, Primary Packaging Glass en Advanced Technologies. Het bedrijf biedt voorvulbare spuiten, plastic en glazen verpakkingsoplossingen, flacons, glazen patronen en ampullen, flessen en containers, en glazen flessen en potten, evenals doppen, sluitingen, applicators en accessoires; ontwikkeling, industrialisatie en contractproductie van medicijnafleveringsprogramma's; project- en kwaliteitsmanagement; en medicijnafgiftesystemen, waaronder inhalatoren, injectie/auto-injectoren, pen-injectoren, infusiesystemen en inhalatiebeoordeling, auto-injectoren en andere diensten.

Gerresheimer AG Samenvatting

Hoe verhouden de winst en inkomsten van Gerresheimer zich tot de beurswaarde?
GXI fundamentele statistieken
Marktkapitalisatie€2.71b
Inkomsten(TTM)€114.30m
Inkomsten(TTM)€2.01b

23.8x

Koers/Winstverhouding

1.3x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
GXI resultatenrekening (TTM)
Inkomsten€2.01b
Kosten van inkomsten€1.43b
Brutowinst€585.40m
Overige uitgaven€471.10m
Inkomsten€114.30m

Laatst gerapporteerde inkomsten

Aug 31, 2024

Volgende inkomensdatum

Feb 26, 2025

Winst per aandeel (EPS)3.31
Brutomarge29.09%
Nettowinstmarge5.68%
Schuld/Eigen Vermogen Verhouding81.7%

Hoe presteerde GXI op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.6%

Huidig dividendrendement

38%

Uitbetalingsratio